New Report Study Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016

"Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016" emphasizes on the currently active CAR-T cell products in research and development. The Report covers the 40+ companies which are active in this field including 27 leading companies with 101 products targeting 44 different antigens and 24 different technologies. The Report provides in-depth analysis on the CAR-T cell profiles covering pre-clinical and clinical studies, Collaborations details and Deal values, Technologies and Targeted antigens. The Report provides the CAR-T licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Report also describes the unmet needs covered by CAR-T cells highlighting the adverse events, which are major concerns in the market for the usage of CAR-T cells.

Ask for Sample Copy of Report - http://www.reportsweb.com/inquiry&RW0001109526/sample

Report Highlights:
- CAR-T cell Therapy Pipeline scenario
- Collaborations & partnering deals
- Current Prominent Research Areas and Key Players
- Pipeline product profiles CAR-T Technologies and Targeted Antigens
- Licensing opportunities
- Market Drivers and Barriers

Scope
- Overview of the global CAR-T cell therapy pipeline scenario, products and associated companies information
- Coverage of global CAR-T cell therapies under development
- Competitive landscape of products for key players and related indications
- Coverage of licensors, collaborators and Development partners, deal terms and deal values estimation
- Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities
- Highlights of licensing & collaboration opportunities and funding details
- Highlights of latest CAR-T technologies and innovative companies
- Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis

Read Report with Complete TOC - http://www.reportsweb.com/chimeric-antigen-receptor-t-cell-immunotherapy-competitive-landscape-technology-and-pipeline-analysis-2016

Reason to buy
- Pipeline intelligence and complete understanding over therapeutics development of CAR-T cell products to exploit opportunities
- Explore outcomes of Pre-clinical and clinical studies and Identify prominent therapeutic areas
- Develop & design strategies to gain competitive advantage by tracking the latest CAR-T technologies and associated innovative companies
- Track in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Uncovering opportunities in the rapidly growing market, Optimize portfolio, keep updated and make the best decisions for business development
- Identifying the upcoming leaders and products in the CAR-T cell therapy market in the coming years
- Understand the CAR-T competitive landscape, plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Key Points from Table of Content

1 Report Introduction
2 Executive Summary Snapshot
3 Executive Summary
4 Introduction
4.1. Chimeric antigen receptor (CAR) T-cells
4.2. History
4.3. CARs and Generations
4.4. Advantages of CAR-T cells
4.5. Adverse Events with CAR T-cell Therapy
5 CAR-T Cell Therapy-Analysis
5.1. CAR-T Collaboration Deals
5.1.1. CAR-T Cells Therapy Collaborations and Deal Year
5.1.2. Collaborations & Deal Value Trends
5.1.4. Companies collaborations for future developments
5.2. CAR-T Acquisitions Deals
5.2.1. CAR-T Cells Therapy Acquisitions Trends
5.2.2. CAR-T Cells Therapy Acquisitions Offerings by Big Giants
5.3. New facilityfor the development of CAR-T cells
5.4. CAR-T Licensing Opportunities
5.5. Pipeline Scenario
5.5.1. Pipeline Products under Development-An Overview
5.5.2. Pipeline Products under Development by Company
5.5.3. CAR T-cells Therapeutic Areas & Companies
5.5.4. CAR-T cells Targeted Antigens
5.5.5. CAR-T Therapies-Clinical trials & Completion Year
5.5.6. CAR T-cell Technologies & Companies Involved
5.5.7. CAR-T Safety Switches & Company involved
5.5.8. Companies with Upcoming CAR-T Therapeutics
6 Pipeline Profiles
8 Upcoming Technologies Better than CARs
9 Market Drivers
10 Market Barriers
11 SWOT Analysis
12 Report Methodology
13 Consulting Services

Inquire to Purchase this Report - http://www.reportsweb.com/inquiry&RW0001109526/discount

About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us: 
Call: +1-646-491-9876
Email: [email protected]

Posted by Rajat Sahni on Monday March 14 2016, 6:56 PM EDT. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0